Norway· NO-ID_2F2EC977-59C3-44D4-8F0A-AC196CE367CC
Flutiform
A formoterol und fluticason product containing fluticasone propionate + formoterol fumarate dihydrate, registered in Norway by Mundipharma AS. The same ATC class is registered in 9 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Formoterol und fluticason is registered in 9 of 19 countries.
Countries holding a registration under ATC R03AK11 (formoterol und fluticason), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 6 of them publish a price we can compare per daily dose
Formoterol und fluticason · ATC R03AK11
9 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Switzerlandprice
The record
At a glance
FEST (Norway)- Active substance
- Fluticasone Propionate + Formoterol Fumarate Dihydrate
- Manufacturer
- Mundipharma AS
- Country
- Norway (NO)
- ATC code
- R03AK11
- ATC class
- Formoterol und Fluticason
- Defined daily dose
- 24 mcg, Inhal
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_2F2EC977-59C3-44D4-8F0A-AC196CE367CC
- no_varenummer466875120NOK 318.3
- gtin7071970000096
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Formoterol und fluticason in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomFlutiform 125micrograms/dose / 5micrograms/dose inhalerMawdsley-Brooks & Company Ltd
- NetherlandsFlutiform 125 microgram / 5 microgram / dosis aerosol, suspensieEuro Registratie Collectief B.V.
- FinlandFlutiformMundipharma Oy
- IrelandFlutiform 125 microgram/5 microgram per metered dose pressurised inhalation, suspensionMundipharma Pharmaceuticals Limited
- SwedenAbriff 125 mikrogram/5 mikrogram/puff Inhalationsspray, suspensionMundipharma AB
- CzechiaFLUTIFORMMundipharma Gesellschaft m.b.H., Vídeň
- SpainFLUTIFORM 125 MICROGRAMOS / 5 MICROGRAMOS/ INHALACION SUPSENSION PARA INHALACION EN ENVASE A PRESIONMundipharma Pharmaceuticals S.L.
- IcelandFlutiformMundipharma A/S
Authorised across Europe · EMA
The same active substance is authorised in 21 EEA countries. Names it is sold under:
- Austria · Flutiform
- Belgium · Flutiform
- Bulgaria · Flutiform
- Cyprus · Flutiform
- Czechia · Flutiform
- Germany · Flutiform
- Denmark · Flutiform
- Spain · Flutiform
- Finland · Flutiform
- France · Flutiform
- United Kingdom (Northern Ireland) · Affera, Flutiform
- Croatia · Flutiform
- Ireland · Flutiform
- Iceland · Flutiform
- Italy · Abriff, Flutiformo
- Luxembourg · Flutiform
- Netherlands · Flutiform
- Portugal · Flutiform
- Sweden · Abriff, Flutiform
- Slovenia · Flutiform
- Slovakia · Flutiform
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/33239aab-9cb1-4fad-a6cd-66e249534a83 GET /v1/drugs/33239aab-9cb1-4fad-a6cd-66e249534a83?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Inhalasjonsaerosol, suspensjon",
"source": "fest",
"status": "A",
"atc_name": "Formoterol og flutikason",
"merkevare_id": "ID_2F2EC977-59C3-44D4-8F0A-AC196CE367CC",
"name_form_strength": "Flutiform inh aerosol, susp 50 mikrog/5 mikrog",
"prescription_group": "C"
}See everything about formoterol und fluticason.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.